Programa Ortomolecular

CONGRESO INTERNACIONAL
Actualizacin y Avances en
Nutricin Clnica y Medicina Ortomolecular
INTERNATIONAL CONGRESS
Updates and advances in clinical

nutrition and orthomolecular medicine
VALENCIA - ESPAA - 15 Y 16 JUNIO 2012
VALENCIA - SPAIN - 15th - 16th JUNE 2012
D SCIENTIFIC
R HEALTH AN
APPLYING FO
AL MINISTRY
ON
GI
RE
E
TH
INTEREST BY
OF HEALTH
Solicitada la acreditacin por la Comisin de Formacin

Continuada de la Comunitat Valenciana, EVES
Applied for accreditation of Continuing Education Committee
of the Valencian Community

BIENVENIDA
WELCOME
Bienvenidos al II Congreso de Avances

en Medicina Ortomolecular y Nutricin
Clnica.
Welcome to the 2nd Congress of

Advances in Orthomolecular Medicine
and Clinical Nutrition.
Tenemos la esperanza de en este da y

medio aportaros actualizaciones y evidencias de la Medicina Ortomolecular.
We hope in this day and a half bring

you updates and evidences of the
orthomolecular medicine
Cada ao contamos con ms soporte de

laboratorios, y asistencia de ms pases.
Every year we have more laboratories

support and assistance from more
countries.
Cualquier especialidad mdica puede, y

debe conocer la suplementacin nutricional y Medicina Ortomolecular, y debe
de aplicarla a sus pacientes, es indistinto que sean gineclogos, cardilogos,
neurlogos, psiquiatras, pediatras, onclogos, etc.
La obligacin de todo mdico es conocer el mximo abanico teraputico, y
una vez valorado, aplicar a los pacientes el tratamiento menos yatrognico
para el paciente, ms seguro y fiable.
Siempre hay que tener presente que
MEDICINA, solo hay UNA, y en su
momento era el arte de curar.
Es el mdico el que debe utilizar la
mejor terapia, la menos agresiva, pero
para ello debe de abrir su mente.
Gracias por su asistencia y espero que
disfruten de esta reunin.
Dr. A. Marco Chover
2
Any medical specialty,can and must

know the nutritional supplementation
and medicine orthomolecular, and must
apply to their patients, is indistinct are
gynecologists, cardiologists, neurologists, psychiatrists, pediatricians, oncologists, etc.
The obligation of all medical is to know
the maximum therapeutic range, and
once valued, apply to patients the
treatment less yatrognico to the
patient, more secure and reliable.
It must always bear in mind that
medicine, there is only one, and at the
time was the art of healing.
Is the doctor which should use the best
therapy, the less aggressive, but this
should open your mind.
Dr. A. Marco Chover
HOTEL MELI PALACIO DE CONGRESOS
VALENCIA - ESPAA - 15 Y 16 JUNIO 2012 / VALENCIA - SPAIN - 15th - 16th JUNE 2012
COMITS
Committees
Comit Honor
Honorific Committee
ILMA. SRA. DA. RITA BARBER NOLLA
Alcaldesa de Valencia
HBLE. SR. D. LUIS E. ROSADO BRETN
Conseller de Sanitat
ILMA. SRA. DA. ROSA FUSTER TORRES
Presidenta del Colegio Oficial de Mdicos de Valencia
ILMA. SRA. DA. M. TERESA GUARDIOLA CHORRO
Presidenta del Colegio Oficial de Farmacuticos de Valencia
Presidente del Congreso

President of the Congress
DR. ANTONIO MARCO CHOVER
Comit Cientfico
Scientific Commitee
Organizacin
Organization
PROF. GERARDO STBING

DR. JOHN GARANT
DR. RAFAEL TORRES
DRA. INMACULADA REIG
D. AMPARO RIPOLL
D. GLORIA MARCO CHOVER
D. SUSANA SERRADELL

PROGRAMA CIENTFICO/Scientific Programme

Viernes 15 / Friday 15th
14.00 a 15.00 h
ENTREGA DE DOCUMENTACIN Y VISITA A LOS STANDS

Distribution of documents and visit to stands
15.00 a 15.30 h
BIENVENIDA Y APERTURA DEL CONGRESO

Welcome and Congress Opening
Dr. Antonio Marco Chover (Spain)
15.30 a 16.25 h
COMPATIBILIDAD MOLECULAR ENTRE ESPECIES.

Nuevas formas teraputicas usando el concepto de compatibilidad transfilogenticos
Molecular compatibility between species.
New therapeutic ways using trans-phylogenic compatibility concept.
Prof. G. Gutirrez (France)
16.25 a 17.20 h
DISRUPCIN ENDOCRINA: COMPUESTOS QUMICOS EMERGENTES

Endocrine disruption: emerging chemical compounds
Prof. Nicols Olea Serrano (Spain)
17.20 a 17.30 h
DISCUSIN
Discussion
17.30 a 18.00 h
PAUSA CAF Y VISITA A LOS STANDS

Exhibition hall visit and coffee break
18.00 a 18.55 h
VIDA EN EL BORDE, UNA APROXIMACIN NUTRACUTICA AL

PATOGNICO BIOFILM INTESTINAL
Life on the Edge - A Nutraceutical Approach to Pathogenic GI Biofilm
Dr. Stephen Olmstead (USA)
18.55 a 19.50 h
EL AGUA DE MAR, MEDIO INDISPENSABLE A LA REGULACIN FISIOLGICA

The sea water, half essential physiological regulation
Dr. Marco Francisco Paya Torres (Spain)
19.50 a 20.00 h
DISCUSIN
Discussion
21.30 a 00.00 h
CENA DEL CONGRESO (INFORMAL)

Congress Dinner (informal)
Restaurante Samaruch. Av. de Neptuno, 58. Tel. 963 556 648. Valencia
Sbado 16 / Saturday 16th

09.00 a 09.55 h
PROGRESOS EN EL CONTROL NATURAL DEL CNCER POR LA

MEDICINA CELULAR
Progress In the Natural Control of Cancer by Cellular Medicine
Dr. Matthias Rath (Germany)
09.55 a 10.50 h
CIDO ASCRBICO Y ATENCIN DEL CNCER ADYUVANTE.

NUEVA CIENCIA SOBRE UNA VIEJA VITAMINA
Ascorbic Acid and Adjunctive Cancer Care - New Science Regarding an
Old Vitamin
Dr. Ron Hunninghake (USA)
10.50 a 11.00 h
DISCUSIN
Discussion
11.00 a 11.30 h

11.30 a 12.25 h
VITAMINA C PUEDE PREVENIR EL DAO DE LA RADIACIN:

ES EL RESULTADO DE LOS TRABAJADORES DE LA PLANTA DE
ENERGA NUCLEAR DE FUKUSHIMA
Vitamin C can prevent radiation damage: Results from Fukushima
nuclear power plant workers
Dr. Atsuo Yanagisawa (Japan)
12.25 a 13.20 h
LAS CAUSAS AMBIENTALES POR MALA NUTRICIN

The environmental causes of poor nutrition
Dr. William Rea (USA)
13.20 a 13.30 h
DISCUSIN
Discussion
13.30 a 15.00 h
COMIDA
Lunch
15.00 a 15.55 h
EL COLESTEROL, LAS ESTATINAS Y LA q -10

Cholesterol, statins, and the q - 10
Dr. Hctor Solorzano del Ro (Mxico)
15.55 a 16.50 h
CMO DETENER EL ENVEJECIMIENTO?

How to stop aging?
Dr. Alfredo Belzuzarri (Spain)
5

16.50 a 17.00 h
DISCUSIN
Discussion
17.00 a 17.25 h

17.25 a 18.20 h
PRUEBAS PARA EL SISTEMA INMUNOLGICO Y CNCER

Tests for the Immune System and Cancer
Dr. E. Vogelaar (Holland)
18.20 a 18.30 h
DISCUSIN
Discussion
18.30 a 19.25 h
HACIA UNA NUEVA TERAPIA INVENTIVA. DIFERENCIA ENTRE

FLOCULOMIQUE Y PROTEMICA
Towards a new inventive therapy. Difference between floculomique and
proteomics
Dr. Eric Reymond (France)
19.25 a 19.50 h
DISMINUCIN DE LOS NIVELES DE VITAMINA D3 EN ESPAA.

PRESENTACIN PRIMERA PARTE DEL ESTUDIO
Decreased levels of vitamin D3 in Spain. First presentation part of
the study
Dra. Francisca Silvestre (Spain)
19.50 a 20.00 h
DISCUSIN
Discussion
20.00 a 20.15 h
CLAUSURA DEL CONGRESO

Closing Speech
PONENTES
Speakers
Gilles Gutierrez submitted his thesis in 1983 and has created the
TEXINFINE laboratory in the same year. TEXINFINE laboratory dedicated to
pharmaceutical developments has developed mainly targeting systems.
Gilles Gutierrez founded the Institute for Cellular Pharmacology in 1997
to continue its research on the interactions made by molecules from the
plant Kingdom on human cells. He received the Louis Pasteur Medal for
research in 2009 and currently directs work on the transmission of nongenetic information between species and cell communication.
Dr. Olmstead (USA)
Chief Science Officer, Prothera, Inc., Klaire Labs, a division of ProThera,

Inc. Reno, Nevada.
BS With Distinction, Biology Major, Chemistry Minor, University of New
Mexico.
MD, School of Medicine, University of New Mexico, Albuquerque, New
Mexico.
Dr. M.F. Pay Torres (France/Spain)
Doctor en Medicina por la Universidad de Montpellier (Francia).

Tesis de Doctorado en Neurologa Accidentes Neurolgicos de los anticoagulantes (1978).
Diplomado en Medicina Manual y Osteopata, Podologa Mdica, Homeopata y Fitoterapia, Acupuntura y Aurculo Medicina.
Director Mdico de los Laboratorios Quinton Internacional, desde su
creacin siendo encargado de la investigacin y en la docencia.
Miembro de la Sociedad Espaola del Dolor.
Miembro de la Asociacin Internacional de Estudio del Dolor (IASP).
Miembro de la Academia de Ciencias de Nueva York (NYAS).
Miembro de la Asociacin Americana de Medicina Ortopdica (AAOM),
(nico espaol miembro).
7

Prof. N. Olea Serrano (Spain)
Catedrtico universidad.
Facultativo especialista de rea Medicina y Ciruga, Facultad de Medicina, Universidad de Granada.
Epidemiologa, Escuela Andaluza Salud Pblica, Universidad de Granada.
Dr. R. Hunninghake (USA)
Benedictine College, Atchison, KS BA 1973.

University of Kansas, Kansas City, KS MD 1976.
Wesley Medical Center, Wichita, KS Internship 1978.
Smoky Hill Family Practice Program, Residency 1982.
Preceptor, University of Kansas, Associate Professor of Family Practice,
University of Kansas.
School of Medicine-Wichita, KS.
Member KANSAS ACADEMY OF FAMILY PHYSICIANS.
Member KANSAS MEDICAL SOCIETY.
Dr. M. Rath (Germany)
University Clinic of Hamburg, Germany and the German Heart Center

in Berlin.
Discovered the connection between vitamin C deficiency and a new
risk factor for heart disease- lipoprotein(a).
Director of Cardiovascular Research at the Linus Pauling Institute in Palo
Alto, California.
Institute in nutritional and Cellular Medicine.
Member of the New York Academy of Sciences, the American Heart
Association and other scientific organizations.
Director, SPIC Salon Medical Clinic.

Kyorin University School of Medicine, Tokyo.
Japanese National Board of Medicine.
Kyorin University Graduate School of Medicine, Tokyo.
M.D.Sci. (Ph.D. equivalent), Kyorin University.
Orthomolecular nutritional approach against radiation exposure.
Intravenous Vitamin C therapy for anti-aging and cance.r
Doctor-Patient Communication.
Dr. H. Solorzano del Ro (Mxico)
Miembro honorario de la Asociacin Hispano Americana de Nutriologa

Alternativa, Ortomolecular, y Antienvejecimiento, A.C.
Presidente de la Sociedad Mdica de Investigaciones Enzimticas, A.C.
Coordinador de Medicina Ortomolecular del Centro de Estudios de
Medicina Integradora de la Universidad Autnoma de Guadalajara
Presidente de la Asociacin Mexicana de Microscopa, A.C.
Profesor de Farmacologa del CUCS de la Universidad de Guadalajara.
Dr. A. Belzuzarri (Spain)

Medical director and founder of the Clnica la Fuente de la Juventud
in Marbella, Spain.
Member of the Colegio de Mdicos de Madrid.
HRT (Hormone Replacement Therapy) with HGH (Human Growth Hormone).
Editor of the British Medical Journal on HRT.
Medical director of the Marbella High Care Clinic.
Member of the SEMAL, SEMCC, Andropause Society and A4 American
Academy of Antiaging Medicine.
University of Utrecht; Biochemistry and Endocrinology.

Director of thrombosis service of Red Cross.
Director of VHD (Vital Health Diagnostics) and ARTC (Autism Research
and Treatment Center).
President of WHF (World Health Foundation).
Director of ZBC Rhijnauwen; By Dutch government recognised clinicalinstitute allowed to use optimal nutrition.
Professor of Clinical Nutrition: Medical faculty of Benadir University.
Dr. E. Reymond (France)
Docteur en mdecine.
Fondateur du CEIA- Centre Europen dInformatique et dAutomation-
(Lyon- Bruxelles- Genve- Valencia- Allemagne).
A exerc la mdecine pendant 40 ans Lacenas F69640 France, en
tant que gnraliste specialise en organothrapie et en protomique.
Actuellement participe la cration dune database spcialise pour la
Protomique Prdictive.
Prventive Participative P4, Genve, et la cration du rseau de
mdecine personnalise du 21me sicle.
9

Ohio State University College of Medicine Columbus, Ohio - Graduated

with M.D.
American Board of Surgery Certification, Thoracic Surgery, Environmental.
Medicine and American Board Certification, Disability Analyst.
American Medical Association.
Texas Medical Association.
Association for Academic Surgery.
American Academy of Environmental Medicine.
Director, Environmental Health Center, Dallas.
Professor Emeritus of Integrative Medicine, Capital University of Integrative
Medicine, June 2006.
Dr. A. Marco Chover (Spain)
10
Licenciado en medicina y ciruga por la Universidad de Valencia en

1982.
Vicepresidente espaol del ECPM (european Council of Doctors for
plurality in medicine), con sede en Brusselas.
Miembro de la Sociedad Espaola de Mdicos Naturistas.
Vicepresidente de la Sociedad Espaola de organoterapia y organologa.
Miembro de la Sociedad ACAM (Colegio Americano de Medicina
Avanzada).
Miembro de la Sociedad internacional de Medicina Ortomolecular.
Autor del libro Revisin de los Oligoelementos y del libro Medicina
ortomolecular.
Experiencia:
Desde el ao 1989 practicando tcnicas de revitalizacin y rejuvenecimiento.
Director mdico de seminarios anti aging impartidos en Valencia, (Espaa), Guatemala, Buenos Aires ( Argentina) Miembro de la Sociedad
alemana HOT (terapia por oxidacin hematogena).
Autor de la segunda publicacin ampliada y revisada de los oligoelementos.
Mdico asesor de laboratorios de Nutrientes.
Dra. F. Silvestre (Spain)
Doctora en Medicina y Ciruga por la Universidad de Valencia.

Master en Medicina Natural, Homeopata y Acupuntura. Universidad
de Valencia.
Master en Metodologa y mejora de la calidad asistencial. Universidad
Autnoma de Barcelona.
Master en Epidemiologa y Salud Pblica. Universidad de Valencia.
Master en Documentacin Mdica. Universidad de Valencia.
Jefe de la Unidad de Documentacin del Distrito Sanitario de Sagunto.
Lneas de investigacin auspiciada por la Conselleria de Sanidad y por
el Fondo de investigaciones Sanitarias del Ministerio de Sanidad, en
aspectos de calidad asistencial, pacientes crnicos, ciruga mayor ambulatoria y coordinacin entre niveles asistenciales.
Miembro del comit cientfico del Congreso Internacional de Actualizaciones y Avances en Nutricin Clnica y Medicina Ortomolecular.
11

ABSTRACTS PONENTES
Speakers Abstracts
MOLECULAR COMPATIBILITY BETWEEN SPECIES. NEW THERAPEUTIC WAYS
USING TRANS-PHYLOGENIC COMPATIBILITY CONCEPT
Plant substances have been used for therapeutic purposes since ancient times. Even today
numerous studies improve our knowledge in the field of herbal medicine. We get to know
more and more about chemical structures produced by plants, but no scientific publication
addresses the issue of how a molecule of the plant Kingdom can be active in the animal
world. We invite you to observe some common metabolism between plants and animals.
The Krebs cycle in the cytoplasm and the respiratory cycle in the mitochondria are identical
for all eukaryotic cells. In all species, eukaryotes cells have common actors for the identical
metabolic pathways. This common identity is due to evolution and the fact that metabolic
proteins and mechanisms are memorized in the DNA found in one common ancestor.
We also observe that phylogeny is reproduced during mammalian ontogenesis. This means
that evolution has not come about exclusively from mutation but also by hybridization and
addition of genes. Noting that since the genome of an individual does not change with
age, we can hypothesize that it must be possible to reactivate silent metabolic pathways
to repair those metabolisms, which we have adopted through evolution of time and which
have become deficient with age. In fact, to maintain homeostasis, living organisms have
implemented metabolic pathways that evolution has made more and more sophisticated
in order to improve their performance. These high-performing pathways thus became
more sensitive to deleterious factors brought about with age.
We suggest you have a look at this transphylogenic compatibility. The observation of
the transphylogenic compatibility not only helps to explain the negative consequences
of some abiotic molecules on homeostasis but especially to open a field of investigation
which allows a new approach on Therapeutics.

THE ENVIRONMENTAL CAUSES OF POOR NUTRITION
The environment is extremely toxic for the individual living in the 21st century. To
counteract the effect of these toxins, the individual needs super nutrition including
vitamins, minerals, amino acids, and certain lipids. Supplementation of these must occur
on an individual basis. The most common environmental incitants that cause nutrient
deficiency are natural gas fumes, pesticides, formaldehyde, oils, and solvents, etc.
12
Prof. N. Olea Serrano (Spain)

DISRUPCIN ENDOCRINA: COMPUESTOS QUMICOS EMERGENTES
La exposicin humana a compuestos txicos ambientales de muy diferente origen es
un hecho bien conocido y bien documentado. A pesar de ello, la asociacin entre exposicin y efecto sobre la salud no siempre se ha establecido con la profundidad que
creemos necesaria. De hecho, en la ltimas dos dcadas han aparecido nuevos datos en
la literatura cientfica especializada que relacionan la exposicin a ciertos compuestos
qumicos, introducidos en el medio ambiente por la actividad humana, con la aparicin
de nuevos sndromes y el desarrollo de enfermedades especficas, de causa no bien conocida, pero que implican una disrupcin del equilibrio hormonal. La preocupacin por
la incidencia creciente de este tipo de alteraciones ha atrado la atencin de clnicos e
investigadores que tratan de formular, con mayor o menor xito, nuevas aproximaciones
conceptuales en la etiologa de la enfermedad y la disrupcin endocrina.
Dr. R. Hunninghake (USA)

ASCORBIC ACID AND ADJUNCTIVE CANCER CARE - NEW SCIENCE REGARDING
AN OLD VITAMIN
More research has been conducted on the ascorbate molecule than any other substance
in the history of science. Yet, because ascorbate is viewed merely as a low dose oral
vitamin, its potential application in septic shock and adjunctive cancer care has been
widely underappreciated due to unfavorable pharmacokinetics. Recent studies on the
parenteral administration of high dose ascorbate demonstrate unexpected pro-oxidant
benefits that, when combined with its counter-regulatory effects upon the profound
inflammation found in sepsis and advanced cancer identify IV ascorbate as a safe and
potent new clinical modality.
Dr. M. Rath (Germany)

PROGRESS IN THE NATURAL CONTROL OF CANCER BY CELLULAR MEDICINE
Independientemente de su origen, todos los tipos de cncer se extienden con el
mismo mecanismo: enzimas que disuelven el colgeno del tejido conjuntivo. Nuestra
investigacin muestra que ciertos micronutrientes pueden bloquear este mecanismo
patgeno y bloquear a su vez, la invasin y metstasis de las clulas cancerosas. Por otra
parte, la sinergia de micronutrientes tambin puede inhibir otros mecanismos claves del
desarrollo del cncer, incluyendo la angiognesis y el crecimiento tumoral. Finalmente,
la sinergia de nutrientes es capaz de inducir la apoptosis de las clulas cancergenas.
Por lo tanto, la sinergia de micronutrientes promete superar los bloqueos teraputicos
convencionales que se usan en las terapias del cncer.
13

Dr. Olmstead (USA)

BIOFILM AND THE YEAST CONNECTION
Candida albicans colonizes most people and is the most significant fungal pathogen
causing localized and systemic infections, allergies, and even triggering autoimmune
disorders such as celiac and Crohns disease. A more controversial chronic, polysomatic
syndrome linked to Candida is chronic candidiasis sensitivity. These patients are
distinguished by a symptomatic response to a diet restricting starches, sugars, and yeastrelated foods and antifungal agents. Candida is highly immunogenic and is associated
with histamine release, increases in proinflammatory cytokines and IgE, decreases in antiinflammatory cytokines, and a decline in natural killer cell function. Candida contains
a cell wall protein that cross-reacts with - and -gliadin. These are all mechanisms
that could explain how Candida causes a systemic, polysymptomatic disorder. C.
albicans as well as other Candida species reside within biofilm. A biofilm is a gathering
of sessile microorganisms encased by a self-generated hydrated exopolysaccharide
matrix, firmly attached to a surface. In addition to exopolysaccharides, biofilm matrix
typically contain proteins, nucleic acids, and di- and trivalent cations. Candida and other
microorganisms live within biofilm because it affords them protection from competitors,
preditors, antimicrobials, host immune responses, and toxins. Biofilm prevents microbial
communities from being dislodged from an environment. Existence in biofilm facilitates
horizontal gene transfer and acquisition of external DNA. It optimizes nutrient utilization
and enables host status sensing. Biofilm formation is an integral part of Candida
colonization on mucosal surfaces and skin. Transition from blastospore to hyphae is an
integral part of biofilm development. As Candida enters into biofilm mode, genes coding
for antifungal resistance and drug efflux pumps are expressed. Additional mechanisms of
antifungal drug resistance manifested by Candida organisms residing within biofilm are
reduced diffusion of antifungals into the biofilm, binding of antifungal drugs by biofilm
matrix carbohydrates such as -glucan, reduced metabolic rates, and the appearance
of highly drug-resistant persister cells. Candida residing within biofilm is highly resistant
to eradication. Within biofilm, Candida remains highly immunogenic stimulating host
defensive immune responses as well as generating allergic and autoimmune reactions.
Immunogenic, colonizing Candida biofilm communities offer an explanation for why
fungal overgrowth is rarely documented in polysomatic symptomatic patients and for
high relapse rates following treatment. A novel approach to treating chronic candidiasis
sensitivity is to employ antibiofilm enzymes and chelating agents to make Candida
eradication more effective. Probiotics such as Saccharomyces boulardii and Lactobacillus
acidophilus have been shown to disrupt Candida biofilm formation and promote
elimination of Candida colonies. Enzymes, chelating agents, and probiotics are novel
therapeutic modalities that may render dietary and antifungal treatment of chronic
candidiasis sensitivity more successful.
14

VITAMIN C CAN PREVENT RADIATION DAMAGE: RESULTS FROM FUKUSHIMA
NUCLEAR POWER PLANT WORKERS
On March 11, 2011, in Japan there was an earthquake and a tsunami with devastating
consequences. It led to a serious nuclear accident at the Fukushima nuclear power plant
with the release of a substantial amount of radiation. Now this nuclear accident has
already been described as the largest accidental release of radiation we have ever
seen, and its not over yet.
On March 29, 2011, The Japanese College of Intravenous Therapy issued official
statement to the government, TEPCO and media to recommend regularly intake of
antioxidant supplements such as Vitamin C to counteract the negative consequence of
long-term low dose radiation exposure as well as to the health of coming generations,
but this statement was ignored.
Primary concern was the protection against radioactive contamination of the population,
of the rescue workers and of the persons, trying to control the nuclear disaster in the
direct surrounding of the nuclear power plant. Recently, we examined cancer-related
gene expression in 16 men aged between 32 and 59 years worked 5-6 weeks in a
radiation contaminated area, collecting contaminated water, measuring radiation levels,
operating heavy machinery, and removing debris at Fukushima nuclear power plant.
Blood samples were obtained to measure whole blood counts and blood chemistry,
plasma levels of free DNA, and 47 cancer related gene expressions. Four workers who
took intravenous vitamin C (25,000 mg) therapy before they went in, and continuously
took anti-oxidative supplements during the working period, had no significant change
in both free DNA and overall cancer risk.
Three workers that did not have preventive intravenous vitamin C had an increase in
calculated cancer risk. After 2 months of intervention with intravenous vitamin C and
oral anti-oxidative nutritional supplements, free DNA returned to normal level and
cancer risk score was significantly decreased (p<0.05).
We concluded that Fukushima nuclear power plant workers should take anti-oxidative
nutrition therapy immediately. Moreover, maintaining optimal anti-oxidation reserve
by taking Vitamin C and other anti-oxidative nutrition is essential for people living in
the low-level radiation contaminated area. In the lecture, the protective mechanism of
radiation injury by Vitamin C and their use for clinical practice will be discussed.
*All presentation slides can be downloaded from: http://www.doctoryourself.com/Radiation_VitC.pptx.pdf
15

Dr. A. Belzuzarri (Spain)

Grandes oligarcas rusos y multimillonarios como Timur Artyomov dueo de la mas grande compaa rusa de telfonos mviles, Dimitry Zimin fundador de las mas importante
compaa de telecomunicaciones rusa, y Oleg Deripaska que controla el aluminio en el
mundo estaran invirtiendo grandes sumas en la investigacin de la fuente de la juventud en forma de medicina.
Concretamente Oleg Deripaska estara dando 5 millones de dolares cada ao al acadmico Vladimir Skulachev quien dice haber desarrollado una sustancia antioxidante capaz
de controlar los radicales libres y curar diversas dolencias. El problema es que Skulachev
hasta la fecha solo se ha tratado a si mismo, por lo que su testimonio, aunque respetable, es muy subjetivo y cuestionable.
Voy a presentarles mi protocolo antienvejecimiento integrativo compuesto por:
1.
Terapia hormonal sustitutiva con hormona del crecimiento. Indiscutible hoy en dia
para detener el envejecimiento. Basta ver en el cine las evoluciones del setenton
Silvester Stallone, para convencerse.
2. Neutralizacin de los radicales libres con el mas poderoso compuesto antioxidante
que existe, basado en los descubrimientos de Bruce Ames, al que he llamado cpsulas Belzuzarri 1.
3. Control del SIRT 1 con Resveratrol para hacer creer al organismo que estamos
haciendo una dieta hipocalrica, que es la manera mas simple y efectiva de detener
el envejecimiento, las cpsulas Belzuzarri 2.
4 Regeneracin de la piel y rejuvenecimiento con el Laser CO2 Fraccionado Superpulsado Derma Xel , que produce un reduccin inmediata del tamao de la piel,
desencadena la produccin endgena de colgeno por los Fibroblastos durante 6
meses, regenerando totalmente la piel, borrando cicatrices y manchas y cerrando
los poros.
No nos atrevemos a decir que nuestro protocolo cura diversas dolencias, pero si presentaremos los resultados del KIMS que sobre 13 mil pacientes durante 13 aos, ha evitado
la aparicin de esas dolencias (incluido el cncer), dolencias que en la poblacin normal han tenido una incidencia abrumadoramente mas numerosa. Puede verse un resumen
en www.youtube.com bajo el ttulo AntiAging Integrative Treatment cuyo link es http://
www.youtube.com/watch?v=4qiw-DjGoN0.
16
Dr. M.F. Pay Torres (France/Spain)

EL AGUA DE MAR, MEDIO INDISPENSABLE A LA REGULACIN FISIOLGICA
Particularidades del Agua de Mar segn el proceso Quinton.
Dos ejemplos: Regulacin de la Tiroides, regulacin del metabolismo seo.
Porqu y como acta.

TESTS FOR THE IMMUNE SYSTEM AND CANCER
Essential nutrients are considered to be essential for human life. Vitamins and minerals
are cofactors of enzymes. Amino acids are part of the all proteins including the immune
system. Essential nutrients also perform many important other functions in the human
body.
A deficiency of one of the more then 40 essential nutrients may cause already a diminished
activity of the immune system. A healthy life is a life with a minimal interference of colds,
flu and other simple infections many people suffer each year several times. To much of
a certain nutrient may also cause a reduced immune system.
It is extremely important for Anti-Aging or reaching optimal health to reduce these
infections to less then once per year. At the same time many of these nutrients are also
important to prevent cancer. Also many of them have been used in the (additional)
treatment of cancer.
Recently is was discovered that the protein in blood that binds vitamin D(Vitamin D
binding protein or Gc globulin) also is important for the immune system. It is supposed
to have a side chain of 3 sugars. T and B cells take away each one sugar. The remaining
substance is called Gc-MAF(Macrophage Activating Factor) needed for the immune
system to attack cancer cells, viruses etc.
Cancer cells and some viruses produce an enzyme called nagalase that splits off all the 3
sugars from the Vitamin D binding protein. The consequence is an deactivated immune
system. Nagalase seems to be a good marker to follow the progress of a cancer patient.
Also for some other diseases related to the immune system.
This test is a valuable addition in cancer treatment besides the analysis of the status of
essential nutrients in the blood/plasma/serum and in the 24-hour urine.
17

Dr. H. Solorzano del Ro (Mxico)

Como en una escena de ciencia ficcin un cientfico anciano, debil y trmulo; bebe una
pcima en su laboratorio, y sbitamente recupera el impetu y el vigor de sus 30 aos;
esto es lo que ha pasado con ratones en un experimento cientfico serio, reproducido
cientos de veces y avalado por gente tan seria como Bruce Ames el cientfico mas galardonado de los Estados Unidos . No sabemos si esto pasar tambin en humanos y hasta
la fecha nos hemos contentado con tomar (yo incluido) dosis homeopticas equivalentes
a la centsima parte de lo que tomaron los ratones. Sabemos que la pcima es inocua,
porqu no intentarlo? (Nota: Por cierto, la Pcima es medicina Ortomolecular en su
ms pura expresin.)
Dr. E. Reymond (France)

HACIA UNA NUEVA TERAPIA INVENTIVA. DIFERENCIA ENTRE FLOCULOMIQUE
Y PROTEMICA
La medicina de los siglos 19 y 20 ha sido una medicina de enfermedades. Los mdicos
y estudiantes de medicina tenan a su disposicin tratados de medicina describiendo las
enfermedades por sistemas orgnicos: enfermedades cardacas, neurolgicas, gstricas,
renales, etc.... Cada enfermedad tena su teraputica.
La medicina del siglo 21 ser la medicina personalizada. Cada paciente tiene su estructura biolgica y su teraputica, sea considerado o no como enfermo. Y su teraputica
puede ser un frmaco o un nutriente. Los tratados de medicina, por supuesto subsistirn. Pero estarn duplicados con base de datos y con banco de datos que transformarn
la prctica de la medicina ortomolecular.
18
Dr. A. Marco Chover / Dra. F. Silvestre (Spain)

DISMINUCIN DE LOS NIVELES DE VITAMINA D3 EN ESPAA. PRESENTACIN
PRIMERA PARTE DEL ESTUDIO.
Las vitaminas liposolubles fueron consideradas en su momento como vitaminas que
podran ser toxicas, y posteriores trabajos las van colocando en su sitio, valorando su
actividad y su verdadera toxicidad.
La vitamina D es una de las vitaminas liposolubles marginadas, y que desde hace pocos
aos ha alcanzado un valor importante dentro de las vitaminas al mismo tiempo que se
ha reconsiderado su toxicidad.
La vitamina D ha pasado en poco tiempo de ser una vitamina, podramos decir de segunda clase, que solo nos serva poco ms que para la prevencin del raquitismo y como
tratamiento la osteomalacia (incapacidad de mineralizar los huesos), de la osteoporosis
sobre todo en las mujeres menopusicas a tener una importancia capital.
Es estimulante y modulador del sistema inmune, cardioprotector, (mejora la TA,) anti
cncer, (ovario, colon, mama, prstata,) protector de la diabetes, preventivo y tratamiento de enfermedades autoinmunes, (Colitis, psoriasis, artritis) control y mantenimiento de
la salud sea, preventivo de enfermedades neurodegenerativas como Alzheimer.
Su dficit provoca debilidad muscular, alteraciones neurolgicas, aumento de riesgo de
fracturas, de cncer, alteraciones inmunes, diabetes, HTA,
La vitamina D es precursora de hormonas esteroideas.
Los niveles de vitamina se suelen encontrar en niveles ms disminuidos de lo que se
podra pensar.
Para conseguir niveles ptimos de vitamina D podra servir la exposicin de 15 minutos
al sol diariamente, sin embargo la capacidad de produccin, la forma de exposicin al
sol y la salud del individuo permiten que tengamos la capacidad de sintetizar ms o
menos vitamina D.
Incluso en pases mediterrneos con abundante sol podemos padecer hipovitaminosis D.
Primera parte de un trabajo observacin.
19

EXPOSITORES
Exhibitors
A
RAD
ENT
21
20
ERCIAL
IN COM
EXPOSIC
15
16
19
11
17
14
9
13
ERCIAL
IN COM
EXPOSIC
8
7
12
10
4
1
LENTIA
SALA VA B)
(A+
Stands
01. ISOM
02. ELN
03. Diafarm
04. Valentia Biologics
05. Suplementos Zeus
06. Laboratoires Quinton
07. Douglas Laboratories
08. Minami Nutrition
09. Laboratorios Nutergia
10. Vitae
20
11. SM
12. Bonusan
13. Dr. Rath Health Foundation
14. Natudelia
15. Farmacia Boix
16. Essential
17. Organo Gold
19. Secretara Tcnica/Technical Secretariat
20. Quesos de Cat
21. PSN
Patrocinadores/Sponsors
Colaboradores/Collaborators
Otros Colaboradores/Other Collaborators

SOCIEDAD ESPAOLA
DE ORGANOTERAPIA
21
Sede del Congreso/Congress Venue

HOTEL MELI VALENCIA
Av. Cortes Valencianas, 52
46015 Valencia - Spain
www.melia-valencia.com
ADA
R
ENT
21
ERCIAL
IN COM
EXPOSIC
15
18
19
16
Actualizacin y Avances
11en 12
10
9
Nutricin Clnica y Medicina
Ortomolecular
14
INTERNATIONAL
CONGRESS
13

nutrition
IALand orthomolecular medicine
OMERC
SICIN C
EXPO
6
VALENCIA
-5 ESPAA - 15 Y 16 JUNIO 2012
VALENCIA - SPAIN - 15th - 16th JUNE 2012
LENCIA
SALA VA C)
(B+
SECRETARA TCNICA:
VIAJES EL CORTE INGLS, S.A. Divisin de Congresos, Convenciones e Incentivos
Gran Va Fernando El Catlico n 3 bajo
Tel.: +34 963 107 189 Fax: +34 963 411 046 46008 Valencia (Espaa)
E-mail: secretaria@congresomedicinaortomolecular.com
Webs: www.congresomedicinaortomolecular.com / www.drmarcochover.com

Programa Ortomolecular

Diunggah oleh

Informasi Dokumen

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

Programa Ortomolecular

Diunggah oleh

Hak Cipta:

Format Tersedia

CONGRESO INTERNACIONAL

Updates and advances in clinical

Solicitada la acreditacin por la Comisin de Formacin

Updates and advances in clinical

Bienvenidos al II Congreso de Avances

Welcome to the 2nd Congress of

Tenemos la esperanza de en este da y

We hope in this day and a half bring

Cada ao contamos con ms soporte de

Every year we have more laboratories

Cualquier especialidad mdica puede, y

Any medical specialty,can and must

Dr. A. Marco Chover

HOTEL MELI PALACIO DE CONGRESOS

Presidente del Congreso

PROF. GERARDO STBING

Updates and advances in clinical

PROGRAMA CIENTFICO/Scientific Programme

ENTREGA DE DOCUMENTACIN Y VISITA A LOS STANDS

BIENVENIDA Y APERTURA DEL CONGRESO

COMPATIBILIDAD MOLECULAR ENTRE ESPECIES.

DISRUPCIN ENDOCRINA: COMPUESTOS QUMICOS EMERGENTES

PAUSA CAF Y VISITA A LOS STANDS

VIDA EN EL BORDE, UNA APROXIMACIN NUTRACUTICA AL

EL AGUA DE MAR, MEDIO INDISPENSABLE A LA REGULACIN FISIOLGICA

CENA DEL CONGRESO (INFORMAL)

HOTEL MELI PALACIO DE CONGRESOS

Sbado 16 / Saturday 16th

PROGRESOS EN EL CONTROL NATURAL DEL CNCER POR LA

CIDO ASCRBICO Y ATENCIN DEL CNCER ADYUVANTE.

PAUSA CAF Y VISITA A LOS STANDS

VITAMINA C PUEDE PREVENIR EL DAO DE LA RADIACIN:

LAS CAUSAS AMBIENTALES POR MALA NUTRICIN

EL COLESTEROL, LAS ESTATINAS Y LA q -10

CMO DETENER EL ENVEJECIMIENTO?

Updates and advances in clinical

PAUSA CAF Y VISITA A LOS STANDS

PRUEBAS PARA EL SISTEMA INMUNOLGICO Y CNCER

HACIA UNA NUEVA TERAPIA INVENTIVA. DIFERENCIA ENTRE

DISMINUCIN DE LOS NIVELES DE VITAMINA D3 EN ESPAA.

CLAUSURA DEL CONGRESO

HOTEL MELI PALACIO DE CONGRESOS

Dr. Olmstead (USA)

Chief Science Officer, Prothera, Inc., Klaire Labs, a division of ProThera,

Dr. M.F. Pay Torres (France/Spain)

Doctor en Medicina por la Universidad de Montpellier (Francia).

Updates and advances in clinical

Prof. N. Olea Serrano (Spain)

Dr. R. Hunninghake (USA)

Benedictine College, Atchison, KS BA 1973.

Dr. M. Rath (Germany)

University Clinic of Hamburg, Germany and the German Heart Center

Dr. Atsuo Yanagisawa (Japan)

Director, SPIC Salon Medical Clinic.

HOTEL MELI PALACIO DE CONGRESOS

Dr. H. Solorzano del Ro (Mxico)

Miembro honorario de la Asociacin Hispano Americana de Nutriologa

Dr. A. Belzuzarri (Spain)

Dr. E. Vogelaar (Holland)

University of Utrecht; Biochemistry and Endocrinology.

Dr. E. Reymond (France)

Updates and advances in clinical

Dr. William Rea (USA)

Ohio State University College of Medicine Columbus, Ohio - Graduated